Latanoprost versus bimatoprost

被引：4

作者：

Eisenberg, D

机构：

来源：

OPHTHALMOLOGY | 2003年 / 110卷 / 09期

关键词：

D O I：

10.1016/S0161-6420(03)00849-2

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

引用

收藏

页码：1861 / 1862

页数：2

相关论文

共 6 条

[1] Bimatoprost and travoprost: A review of recent studies of two new glaucoma drugs [J].

Eisenberg, DL ;

Toris, CB ;

Camras, CB .

SURVEY OF OPHTHALMOLOGY, 2002, 47 :S105-S115

[2] Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension [J].

Gandolfi, S ;

Simmons, ST ;

Sturm, R ;

Chen, KK ;

Vandenburgh, AM .

ADVANCES IN THERAPY, 2001, 18 (03) :110-121

[3] Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost [J].

Gandolfi, SA ;

Cimino, L .

OPHTHALMOLOGY, 2003, 110 (03) :609-614

[4] The hydrolysis of bimatoprost in corneal tissue generates a potent prostanoid FP receptor agonist [J].

Maxey, KM ;

Johnson, JL ;

LaBrecque, J .

SURVEY OF OPHTHALMOLOGY, 2002, 47 :S34-S40

[5] Agonist activity of bimatoprost, travoprost, latanoprost, unoprostone isopropyl ester and other prostaglandin analogs at the cloned human ciliary body FP prostaglandin receptor [J].

Sharif, NA ;

Kelly, CR ;

Crider, JY .

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2002, 18 (04) :313-324

[6] The pharmacology of bimatoprost (Lumigan™) [J].

Woodward, DF ;

Krauss, AHP ;

Chen, J ;

Lai, RK ;

Spada, CS ;

Burk, RM ;

Andrews, SW ;

Shi, L ;

Liang, Y ;

Kedzie, KM ;

Chen, R ;

Gil, DW ;

Kharlamb, A ;

Archeampong, A ;

Ling, J ;

Madhu, C ;

Ni, J ;

Rix, P ;

Usansky, J ;

Usansky, H ;

Weber, A ;

Welty, D ;

Yang, W ;

Tang-Liu, DDS ;

Garst, ME ;

Brar, B ;

Wheeler, LA ;

Kaplan, LJ .

SURVEY OF OPHTHALMOLOGY, 2001, 45 :S337-S345